- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03353519
Improving Primary Care After Stroke (IPCAS) (IPCAS)
Improving Primary Care After Stroke (IPCAS): A Randomised Controlled Trial to Evaluate a New Model of Care for Stroke Survivors Living in the Community
No formal primary care based model of care exists to support stroke survivors living in the community. A large variation in the range, quality and access to health services offered to stroke survivors between and within local clinical commissioning groups suggests that many of the stroke survivors' needs are not being met systematically. Therefore, to address the longer term needs we have developed a multi-factorial primary care model that seeks to enable greater engagement with stroke care and community services, to link effectively to specialist services, and to improve the lives of stroke survivors.
This will be a two-arm cluster randomised controlled trial. Participating general practices will be randomised to deliver either the new model of stroke care or current usual care. The aim of this trial will be to assess the clinical and long-term cost effectiveness of the new model of primary care for stroke survivors living in the community. The primary outcome for the trial will be measured using two sub-scales (emotion and handicap) of the Stroke Impact Scale questionnaire at 12 months.
Study Overview
Detailed Description
The IPCAS trial is a two-arm cluster randomised controlled trial with general practices as the unit of randomisation. The aim of this trial is to evaluate the clinical and long-term cost effectiveness of a novel model of primary care for stroke survivors living in the community.
People with a history of stroke on the registers of GP practices in the East of England and the East Midlands will be invited to take part. We will aim to recruit approximately 920 people registered with 46 general practices. We will target Practices with a stroke register comprising a minimum of 100 patients, to ensure that we reach our cluster target of 16 - 24 participants.
Potentially eligible participants will be sent an invitation to take part in the study by their GP surgery. Once all invitation letters and reminders have been sent out to patients in a practice, the GP practice will be randomised. GP practices will be randomised in a ratio of 1:1 to intervention or control. Intervention practices will deliver the new model of primary care. The control arm will consist of current usual care.
Data collection will occur at baseline and at 6 and 12 months. This will comprise a combination of postal and telephone administered questionnaires and a review of general practice notes. The primary endpoint for the trial will be two sub-scales (emotion and handicap) of the Stroke Impact Scale (SIS v3.0) as co-primary outcomes at 12 months (adjusted for baseline). Economic evaluation as well as quantitative and qualitative assessments of intervention fidelity will also be performed.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Leicester, United Kingdom
- CRN East Midlands
-
Norwich, United Kingdom
- CRN Eastern
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- On practice register with a history of stroke.
- Able to provide written informed consent (with or without the help of a carer).
- Age 18 years or older.
Exclusion Criteria:
- Patients on the palliative care register.
- Patients living in a nursing home.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Primary care model
The new model of care incorporates a multi-factorial package of service aimed at providing a review of patient needs, facilitated self-management of longer-term stroke care needs for survivors and their carers, optimised communication between patients and health and social care services, optimised communication between the different care services, and increased awareness of and access to national and local community and charity provided services.
|
Specifically, the intervention will comprise the following components:
|
NO_INTERVENTION: Usual care
The control arm will consist of the usual care currently provided for stroke survivors registered with each general practice.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Stroke Impact Scale (SIS v3.0)
Time Frame: 12 months after attendance at a review
|
The primary endpoint for the trial will be two sub-scales (emotion and handicap) of the Stroke Impact Scale as co-primary outcomes.
The SIS is a 59-item mail administered stroke-specific health-related quality of life (HRQoL) measure.
Each item is rated on a 5 point Likert scale with answers based on the level of difficulty.
|
12 months after attendance at a review
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Stroke Impact Scale Short Form (SIS-SF)
Time Frame: 6 and 12 months after attendance at a review
|
The SIS Short Form consists of 8 items comprising one question from each of the SIS domains (strength, hand function, mobility, activities of daily living, memory, communication, emotion and handicap).
Each item is rated on a 5 point Likert scale with answers based on the level of difficulty.
|
6 and 12 months after attendance at a review
|
EQ-5D-5L
Time Frame: 6 and 12 months after attendance at a review
|
The EQ-5D-5L is a standardised measure of health status suitable for health and economic appraisal.
The responses to 5 dimensions can be combined to provide a 5 digit profile.
The profile can be converted using a link function to a single index value which facilitates the calculation of quality-adjusted life years (QALYs).
The questionnaire will be used to allow for economic evaluation.
|
6 and 12 months after attendance at a review
|
ICEpop CAPability measure for Adults (ICECAP-A)
Time Frame: 6 and 12 months after attendance at a review
|
ICECAP-A is also used in economic evaluation.
The ICECAP-A focuses on wellbeing defined in a broader sense rather than health.
It comprises of 5 attributes: Attachment, Stability, Achievement, Enjoyment and Autonomy.
Each attribute is judged on a 4-point Likert scale ranging from full capability to no capability.
|
6 and 12 months after attendance at a review
|
Southampton Stroke Self-management Questionnaire (SSSQ)
Time Frame: 12 months after attendance at a review
|
SSSQ is a 28 item scale covering aspects of managing health and communication with health care professionals.
|
12 months after attendance at a review
|
Health Literacy Questionnaire (HLQ)
Time Frame: 12 months after attendance at a review
|
The HLQ is a self-report measure of patients' strengths and limitations in their ability to access, understand and effectively use health information and services.
It has 44 items covering the following 9 domains: (1) feeling understood and supported by healthcare providers; (2) having sufficient information to manage health; (3) actively managing health; (4) social support for health; (5) appraisal of health information; (6) ability to actively engage with healthcare providers; (7) navigating the healthcare system; (8) ability to find good health information; (9) understand health information.
|
12 months after attendance at a review
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
General Publications
- Blatchford EG, Aquino MRJ, Grant J, Johnson V, Mullis R, Lim L, Mant J. Patients' experience of and participation in a stroke self-management programme, My Life After Stroke (MLAS): a multimethod study. BMJ Open. 2022 Nov 15;12(11):e062700. doi: 10.1136/bmjopen-2022-062700.
- Aquino MRJR, Mullis R, Kreit E, Johnson V, Grant J, Lim L, Sutton S, Mant J. Improving Primary Care After Stroke (IPCAS) randomised controlled trial: protocol for a multidimensional process evaluation. BMJ Open. 2020 Jul 8;10(7):e036879. doi: 10.1136/bmjopen-2020-036879.
- Mullis R, Aquino MRJR, Dawson SN, Johnson V, Jowett S, Kreit E, Mant J; IPCAS investigator team. Improving Primary Care After Stroke (IPCAS) trial: protocol of a randomised controlled trial to evaluate a novel model of care for stroke survivors living in the community. BMJ Open. 2019 Aug 18;9(8):e030285. doi: 10.1136/bmjopen-2019-030285.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RG71908
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamActive, not recruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationActive, not recruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
Clinical Trials on Primary care model
-
US Department of Veterans AffairsCompleted
-
University of MichiganNational Heart, Lung, and Blood Institute (NHLBI); Institute of Nutrition of... and other collaboratorsEnrolling by invitationCardiovascular Diseases | Hypertension | Diabetes Mellitus, Type 2Guatemala
-
Duke UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingPain, BackUnited States
-
University of WaterlooUniversity of British Columbia; University of Calgary; Dalhousie University; Laval...Completed
-
University of ArizonaUnknown
-
Yale UniversityAmerican Cancer Society, Inc.CompletedChildhood Cancer
-
Kaiser PermanenteNational Cancer Institute (NCI)Active, not recruitingBreast Cancer | Colorectal CancerUnited States
-
Queen's UniversityCanadian Institutes of Health Research (CIHR); The Arthritis Society, CanadaRecruitingKnee Osteoarthritis | Hip OsteoarthritisCanada
-
Jordan Miller, PT, PhDCanadian Institutes of Health Research (CIHR); The Arthritis Society, CanadaRecruitingKnee Osteoarthritis | Hip OsteoarthritisCanada